Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, Research Support, U.S. Gov't, P.H.S.
Grantová podpora
CA-27834
NCI NIH HHS - United States
TW00050
FIC NIH HHS - United States
PubMed
7815488
PubMed Central
PMC188681
DOI
10.1128/jvi.69.2.1093-1098.1995
Knihovny.cz E-zdroje
- MeSH
- buněčné inkluze virové MeSH
- Escherichia coli genetika ultrastruktura MeSH
- genové produkty gag metabolismus MeSH
- HeLa buňky MeSH
- kapsida metabolismus MeSH
- lidé MeSH
- Masonův-Pfizerův opičí virus metabolismus ultrastruktura MeSH
- proteinové prekurzory metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Názvy látek
- genové produkty gag MeSH
- proteinové prekurzory MeSH
The capsid precursor protein (Gag) of Mason-Pfizer monkey virus, the prototype type D retrovirus, has been expressed to high levels in bacteria under the control of the phage T7 promoter. Electron microscopic studies of induced cells revealed the assembly of capsid-like structures within inclusion bodies that formed at the poles of the cells 6 h after induction with isopropyl-beta-D-thiogalactopyranoside (IPTG). The inclusion bodies and enclosed capsid-like structures were solubilized completely in 8 M urea, but following renaturation, we observed assembly in vitro of capsid-like structures that demonstrated apparent icosahedral symmetry. These results demonstrate for the first time that retroviral capsid precursors have the propensity to self-assemble in vitro and point to new approaches for the analysis of retroviral assembly and structure.
Zobrazit více v PubMed
Cold Spring Harb Symp Quant Biol. 1975;39 Pt 2:1067-75 PubMed
Cancer Res. 1978 Oct;38(10):3123-39 PubMed
Nature. 1985 Sep 12-18;317(6033):145-53 PubMed
Cell. 1986 Sep 12;46(6):895-904 PubMed
J Mol Biol. 1986 Oct 20;191(4):639-58 PubMed
J Virol. 1987 Apr;61(4):1045-53 PubMed
Virology. 1987 May;158(1):248-50 PubMed
Biochim Biophys Acta. 1987 Jul 8;907(2):93-123 PubMed
Lab Invest. 1988 Jan;58(1):112-8 PubMed
J Virol. 1989 Oct;63(10):4331-43 PubMed
Cell. 1989 Oct 6;59(1):103-12 PubMed
EMBO J. 1989 Sep;8(9):2653-60 PubMed
J Virol. 1990 May;64(5):2265-79 PubMed
J Virol. 1990 Jun;64(6):2653-9 PubMed
J Virol. 1990 Jun;64(6):2743-50 PubMed
Methods Enzymol. 1990;185:60-89 PubMed
Cell. 1990 Oct 5;63(1):77-86 PubMed
EMBO J. 1991 Mar;10(3):535-46 PubMed
J Virol. 1991 Jul;65(7):3804-12 PubMed
AIDS. 1991 Jun;5(6):639-54 PubMed
Nature. 1991 Nov 28;354(6351):278-84 PubMed
EMBO J. 1992 Mar;11(3):1155-64 PubMed
J Virol. 1992 Aug;66(8):4874-83 PubMed
J Virol. 1992 Sep;66(9):5615-20 PubMed
J Virol. 1992 Dec;66(12):7005-11 PubMed
J Virol. 1992 Dec;66(12):7021-32 PubMed
J Virol. 1993 Apr;67(4):1936-44 PubMed
J Virol. 1993 Aug;67(8):4972-80 PubMed
J Virol. 1993 Dec;67(12):6929-36 PubMed
AIDS Res Hum Retroviruses. 1993 Oct;9(10):929-38 PubMed
In vitro methods for testing antiviral drugs
Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging
In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV